A Service of UA Little Rock
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Oral Arguments Set Over Johnson & Johnson Appeal Of $1 Billion Fine

Arkansas Supreme Court

The Arkansas Supreme Court has scheduled oral arguments in Johnson & Johnson's request to overturn a verdict and $1.2 billion fine over the marketing of the antipsychotics drug Risperdal.

Oral arguments are set for Feb. 27 in Little Rock for the appeal from Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, Inc.

Attorney General Dustin McDaniel successfully sued the companies, claiming they downplayed and hid risks associated with taking Risperdal.

In 2012, a Pulaski County judge fined the two companies $5,000 for each of 240,000 Risperdal prescriptions the state Medicaid program paid for during a 3 1/2-year period.

In a separate case, Johnson & Johnson agreed to a $2.2 billion settlement with the U.S. Department of Justice in November over allegations that it promoted three drugs, including Risperdal, for off-label uses.

The Associated Press is one of the largest and most trusted sources of independent newsgathering, supplying a steady stream of news to its members, international subscribers and commercial customers. AP is neither privately owned nor government-funded; instead, it's a not-for-profit news cooperative owned by its American newspaper and broadcast members.